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Abstract
This article reviews neuroimaging, neurocognitive, and preclinical findings on the effects of
cannabis on the adolescent brain. Marijuana is the second most widely used intoxicant in
adolescence, and teens who engage in heavy marijuana use often show disadvantages in
neurocognitive performance, macrostructural and microstructural brain development, and
alterations in brain functioning. It remains unclear whether such disadvantages reflect pre-existing
differences that lead to increased substances use and further changes in brain architecture and
behavioral outcomes. Future work should focus on prospective investigations to help disentangle
dose-dependent effects from pre-existing effects, and to better understand the interactive
relationships with other commonly abused substances (e.g., alcohol) to better understand the role
of regular cannabis use on neurodevelopmental trajectories.
Introduction
According to the 2011 Monitoring the Future Study, marijuana remains the most commonly
used illicit drug in adolescence in the United States, one of few increasing in prevalence. In
fact, marijuana has been the most commonly used illicit substance for almost 40 years, and
presently 23% of 12th graders in the U.S. report using marijuana in the past month [1].
Marijuana use in adolescence could have implications for academic functioning, as well as
social and occupational functioning extending into later life. Maturational brain changes,
particularly myelination and synaptic pruning, are occurring throughout adolescence, well
into early adulthood [2]. These remodeling processes are purportedly linked to efficient
neural processing, and believed to underlie specialized cognitive processing necessary for
optimal neurocognitive performance.
Cannabinoid receptors (CB1) are widely distributed throughout the brain (e.g.,
hippocampus, prefrontal cortex), and play a role in neurotransmitter release and
concentrations across neural systems (excitatory and inhibitory). It has been suggested that
these receptors increase during adolescence, have a role in genetic expression of neural
development, and that alteration of the endocannabinoid system during adolescence may
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results in a cascade of neurochemical and neurostructural aberrations, thus leading to poorer
cognitive and emotional outcomes in adulthood [3, 4].
Disruptions in brain development related to neurotoxic effects of regular marijuana use
could significantly alter neurodevelopmental trajectories by not only changing
neurochemical communication and genetic expression of neural development, but causing a
toxic effect on brain tissue. Such a marijuana-related effect on white matter and gray matter
structures (e.g., changes in myelin, axons, and synapses) could have widespread
implications for healthy brain development from childhood to young adulthood on subtle
cognitive functioning and success in daily functioning. Studies exploring the neurocognitive
consequences and structural and functional neuroimaging changes related to marijuana use
in adolescence will be discussed, along with recommendations for future work.
Cognition
Adult studies of marijuana use often find subtle decreases in performance compared to
controls in cognitive domains such as attention, memory, and processing speed; such effects
have been discussed as transient in the literature given limited group differences after
prolonged abstinence from marijuana [5, 6]. It is unclear if findings translate to adolescent
populations. Ongoing cognitive development in the domains of memory and executive
functioning, and particularly in specialized functions like cognitive control, is not only
tightly associated with adolescence and neocortical tissue maturation, but is likely to have
implications for school performance and engagement in risk/reward behaviors [7]. One of
the earliest studies on the effects of marijuana on adolescent neurocognitive development
evaluated verbal and nonverbal memory performance in cannabis-dependent adolescents
(ages 14 to 16) compared to matched controls [8]. Schwartz and colleagues found that short-
term memory impairment persisted after six weeks of monitored abstinence. In contrast,
Teichner and colleagues (2000) found no relationship between marijuana use severity and
cognitive performance among cognitively impaired and unimpaired adolescents referred for
drug treatment [9]. There have been considerable additions to the literature over the last
decade, yet the degree of impairment related to marijuana use in adolescence remains
inconclusive. A pattern of subtle yet potentially detrimental effects in cognitive domains
related to attention, learning, and memory are most often described.
A prospective study conducted in 2005 examined neurocognitive performance among 17–21
year olds with history of soft drug exposure in utero compared to prior performance at 9–12
years old. Current heavy cannabis users performed significantly worse on measures of
processing speed and memory, controlling for pre-drug performance. Notably, former heavy
users (reporting 3 months without regular use) had similar scores to non-marijuana using
controls [10]. In regard to higher-order cognitive functioning, Lane and colleagues (2007)
found adolescents (ages 14–18) with histories of heavy marijuana use performed worse on
perseverative responding and flexible thinking compared to controls with limited histories of
use. This same research group also found evidence of reduced motivation among marijuana
users compared to controls [11, 12]. In 2007, Harvey and colleagues found adolescent
marijuana users (age 13–18; use greater than once per week) performed worse on tests of
Jacobus and Tapert Page 2
Curr Pharm Des. Author manuscript; available in PMC 2015 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
attention, learning, and memory; furthermore, poorer performance on executive functioning
in this sample was related to more days of cannabis use in the past month [13].
Studies from our laboratory have largely found differences in similar domains following
four weeks of monitored abstinence. Our first prospective investigation found that
cumulative marijuana use over the course of eight years (teens followed from ages 13–30)
was related to poorer performance on measures of attentional functioning [14]. In a
subsequent cross-sectional study of adolescent marijuana users ages 16–18, we found that
marijuana users demonstrated slower processing speed, poorer verbal learning and memory,
and sequencing abilities [15]. In order to better understand acute changes with abstinence,
we examined neurocognitive performance over 3 weeks of monitored abstinence in
marijuana users ages 15–19. Between-group differences in attention, learning, and memory
were identified at baseline, however while learning and memory performance reached
similar levels of performance to controls after 3 weeks of abstinence, attention differences
persisted [16].
Group differences in our studies generally persist despite controlling for alcohol use present
in both controls and marijuana users; but to further understand differential contributions of
marijuana and alcohol to neurocognitive functioning in our sample, we examined unique
associations between alcohol use severity and cognitive functioning in both marijuana users
as well as controls. In a recent investigation, we found that more self-reported alcohol
withdrawal symptoms predicted poorer performance on learning and memory in a sample of
non-marijuana using teens with histories of episodic alcohol use, despite no relationship in
our marijuana users with similar and/or heavier self-reported history of alcohol use [17].
This suggests differential relationships between marijuana, alcohol, and cognitive outcomes
in our sample. We have observed similar relationships in magnetic resonance imaging
(MRI) studies examining structural and functional brain alterations [18–20], which will be
discussed in greater detail below.
In recent work, Tait and colleagues looked at young adult cannabis users (ages 20–24) and
found memory deficits, however cessation of cannabis use was associated with improved
performance with abstinence over the course of eight years [21]. Takagi and colleagues
found that cannabis users (ages 13–24) performed worse on measures of immediate and
delayed verbal memory compared to community controls. In a similar study by this team of
investigators, no differences between cannabis users and community controls were found on
measures of executive functioning [22, 23]. Similarly Gonzalez and colleagues (2012) found
differences on immediate and delayed recall among young adult cannabis users
(approximately age 20) compared to nonusing controls, however no differences were
observed on measures of impulsivity. Despite no group differences on impulsivity, the
authors found that worse performance on a decision making task was related to more
cannabis use disorder symptoms [24]. Solowij and colleagues looked at 181 adolescents
(ages 16–20) and found that cannabis users performed worse on learning and recall, and
poorer performance was related to severity, frequency, and age of initiation of cannabis use
[25]. A study on prospective memory evaluated undergraduates between the ages of 18 and
24 years old, while no differences in self-reported prospective memory was identified,
cannabis users did recall fewer location-action combinations during the objective video-
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based prospective memory task [26]. A large-scale (N = 1037) longitudinal investigation
from New Zealand evaluating individuals from birth to age 38 recently found a decline in
intelligence quotient, particularly executive functioning and processing speed, with
persistent cannabis dependence. Notably, those individuals with weekly use before age 18
demonstrated greater decline in cognitive performance [27].
Early/Late Onset of Use—Studies evaluating early- and late-onset marijuana users have
provided considerable insight into the effects of cannabis use on adolescent
neurodevelopment. For example, Ehrenreich and colleagues (1999) found that initiation of
marijuana use prior to age 16 predicted impaired reaction time on a task of sustained
attentional processing [28]. In 2003, Pope and colleagues also found that early-onset (or
initiation prior to age 17) was related to poorer performance on verbal memory and fluency
tasks, as well as verbal IQ [29]. Focusing on executive functioning, Fontes and colleagues
(2011) examined 104 chronic cannabis users ages 18–55. All participants met criteria for
DSM-IV cannabis abuse or dependence. The authors found that adolescent cannabis users
reporting initiation prior to age 15 demonstrated poorer performance on tasks of sustained
attention, impulse control, and executive functioning [30]. Overall, the majority of data
support poorer cognitive performance on measures of attention and learning, and memory in
adolescent users of cannabis, however frequency and severity of use is likely to play a role,
particularly in those reporting younger age of initiation. Further, some evidence suggests
that many of the subtle cognitive effects are likely to resolve after longer-term abstinence.
Structural NeuroImaging
Gray Matter Macrostructure—A large body of literature has shown dynamic changes in
gray matter structures that are ongoing over adolescent development (e.g., cortical volume
decline after about 6 years of age). For instance, dendritic pruning and elimination of
synapses likely results in cortical thinning and decreased cerebral volume (e.g., subtraction
of overproduced or weaker synaptic connections) to some degree, whereas some subcortical
structures such as the hippocampus and amygdala have been shown to increase with age [2,
31, 32]. Studies show a high density of CB1 cannabinoid receptors in neocortex,
hippocampus, amygdala, hypothalamus, basal ganglia, and cerebellum [4]; therefore the
degree to which cannabis use alters cortical and subcortical gray matter tissue development
is being increasingly explored in the literature. While some alterations in gray matter
macrostructure have been suggested, there has been inconsistent evidence of morphological
changes as evaluated by structural MRI. For instance, Block and colleagues (1999) as well
as DeLisi and colleagues (2006) found no differences in gray matter tissue volume between
adolescent cannabis users and matched controls [33, 34].
In 2010, adolescent cannabis abusers (ages 16–19) were found to have decreased right
medial orbital prefrontal cortex volume compared to non-using counterparts; volume was
also found to be positively correlated with age of initiation of marijuana use in the sample
(i.e., younger age of first use associated with reduced orbital prefrontal cortex volume) [35].
A second study published in 2010 found that while age was associated with changes in brain
morphometry among non-users, there was no relationship between age and cortical
gyrification in adolescent and young adult cannabis users. Cannabis users did show
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decreased concavity of the sulci and sulci thinning in frontal, temporal, and parietal lobes
compared to non-users, highlighting the potential for cannabis to disrupt normal brain
developmental trajectories [36]. Ashtari and colleagues (2011) found that heavy adolescent
cannabis users abstinent for a minimum of 30 days had smaller bilateral hippocampal
volumes compared to controls, and smaller right hippocampal volume was correlated with
more self-reported cannabis use among users; no between group differences were observed
in amygdala volume [37].
Several studies from our laboratory evaluating abstinent adolescent cannabis users
(approximately ages 16–19) have found similar outcomes in regard to gray matter
macrostructural changes. Medina and colleagues (2007 and 2009) found no difference in
hippocampal volumes or prefrontal cortex volume in adolescent cannabis users compared to
matched controls, despite observed differences in both hippocampus and prefrontal cortex in
adolescent alcohol users compared to matched controls [19, 38]. We did observe a subtle
gender interaction, as female cannabis users had a slightly larger prefrontal cortex compared
to non-using female controls; while this trend did not reach statistical significance, it may
suggest that female marijuana users are more vulnerable to macrostructural alterations
(given smaller prefrontal cortex volume was related to better executive functioning among
users). Similarly, in 2011, amygdala volumes were compared between adolescent cannabis
users and non-users. Findings suggest increased amygdala volume in female users compared
to female non-users. Increased amygdala volume was associated with more self-reported
depression and anxiety (internalizing) symptoms [39]. In a study investigating differences in
cerebellum volumes, we found that adolescent marijuana users demonstrated larger inferior
posterior vermis volume compared to controls; larger cerebellar volume was associated with
poorer executive functioning [40].
In recent investigation of temporal lobe structures, Cousijn and colleagues (2012) found that
amygdala and hippocampal volume in a sample of young adults ages 18–25 correlated
negatively with amount of cannabis use. Specifically, more weekly cannabis use in grams
was related to smaller hippocampus volume in heavy users and increased severity of
cannabis use was associated with smaller amygdala volume. The authors also found that
anterior cerebellum volume was larger in adolescent heavy cannabis users compared to non-
users [41].
A prospective study looking at gray matter volume at 12 years of age, prior to initiation of
marijuana, found that smaller orbitofrontal cortex volume predicted initiation of cannabis
use by 16 years of age, suggesting pre-existing structural abnormalities may play a role in
both behavioral differences that lead to cannabis use as well as continued differences in the
course of development [42].
There have been limited studies evaluating cortical thickness exclusively, however, Lopez-
Larson (2011) evaluated 18 adolescents (ages 16–19) with histories of heavy marijuana use
(at least 100 marijuana use episodes in the past year) compared to non-using controls.
Decreased cortical thickness was reported in the right caudal middle frontal and bilateral
superior frontal cortices; decreased thickness was also found in the bilateral insula.
Marijuana users demonstrated increased cortical thickness in the bilateral lingual, right
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superior temporal, right parietal and left paracentral regions. Alterations of cortical thickness
were related to severity of cannabis use and younger age of initiation of use in several brain
regions. The authors suggest that marijuana may affect neurodevelopment (e.g., increased/
decreased in cortical thickness) in two ways, 1) premature development and/or alterations in
neurodevelopmental trajectories or 2) tissue loss or remodeling associated with marijuana-
related toxicity [43].
Similar to findings by Lopez-Larson discussed above, the concept of deleterious effects
related to early initiation of cannabis has been explored in the neuroimaging literature as
well. According to Wilson and colleagues (2000), individuals reporting marijuana use prior
to age 17 demonstrated decreased whole brain and cortical gray matter in addition to
increased percent white matter volume. Findings also included higher cerebral blood flow in
males reporting early initiation of marijuana use [44]. While findings do not necessarily
support a clear and consistent pattern of changes in cortical/subcortical volume and
thickness measurements, as emphasized by Lopez-Larson and colleagues, we can conclude
that marijuana may influence the trajectories of appreciable gray matter changes in several
ways. The compound may illicit premature tissue development, impose a marijuana-related
effect on regressive changes (e.g., synaptic pruning, death of overproduced cells), and alter
ongoing myelination of fiber tracts that are impacting gray matter estimates. Functional
changes likely affect the mechanics that underlie structural brain changes, and interactions
between these processes cannot be ruled out.
White Matter Microstructure—White matter tissue integrity (e.g., myelination,
coherence of fiber tracts) is believed to be important for efficient cortical connectivity in the
developing brain. The literature has shown linear increases in white matter over early
development. As the brain becomes increasingly myelinated and fiber bundles mature from
infancy to late adolescence, restriction of diffusing water molecules along the principal axis
of an axon is commonly observed due to increasingly compact fibers and with more limited
intracellular space [45, 46]. Diffusion tensor imaging (DTI) commonly utilizes two indices
of white matter tract coherence to reflect water diffusion in white matter, fractional
anisotropy (FA) and mean diffusivity (MD), which are thought to help to identify alterations
in the health of white matter fibers. Increases in FA and decreases in MD are typically seen
in healthy white matter development from young children to early adulthood [45]. In 2006,
DeLisi and colleagues published one of the earlier studies to explore the potential for
deleterious effects of cannabis on developing white matter.. The authors found higher FA
and lower in MD in several tracts in MJ users compared to matched controls; they conclude
no evidence of pathological white matter changes despite finding differences between
groups [33]. Since this study, findings do suggest some evidence of alterations in white
matter integrity in adolescent cannabis users. While DeLisi and colleagues suggest no
evidence of pathology per se, subsequent studies have since shown changes in unanticipated
directions [47]. While this may not represent a typical pathological process, group
differences in either direction may still be reflective of a neural alterations.
For instance, increased MD in the prefrontal fiber bundles of the corpus callosum in heavy
cannabis using adults (daily use for more than two years) who initiated use during
adolescence suggest changes in white matter development associated with cannabis use [48].
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Ashtari and colleagues (2009) found that adolescents with heavy cannabis use enrolled in
residential drug treatment had reduced FA and increased MD in cortical association areas
such as the temporal-parietal fiber tracts [49]. Recently, in a small sample of adolescents
approximately 18 years of age, WM alterations were found in cannabis users compared to
controls. Decreased FA in cortical and subcortical areas (e.g., hippocampal projections,
superior longitudinal fasciculus) was found in cannabis users (weekly use for at least one
year) compared to controls with no history of substance abuse [50].
In our laboratory, we have found white matter alterations in our abstinent teen marijuana
users (ages 16–19) compared to controls. In two studies published in 2008 and 2009, we
found poorer white matter integrity (e.g., decreased FA and increased MD) in several
association and projection fiber tracts in adolescent cannabis users with concomitant alcohol
use. Areas showing between group differences included tracts linked to fronto-parietal
circuitry [51]. White matter integrity in several of these regions was linked to
neurocognitive performance on measures of attention, working memory, and processing
speed; we have also seen white matter linked to emotional functioning and prospective risk
taking in our substance users [52, 53]. To better understand microstructural differences in
tissue integrity among adolescent marijuana users as compared to binge drinkers, we looked
at white matter differences between adolescent binge drinkers compared to binge drinkers
with histories of heavy marijuana use (ages 16–19). While between group differences
persisted between marijuana users and controls, surprisingly, teens engaging in binge
drinking only looked significantly worse on indices of white matter integrity (i.e., decreased
FA) in several areas (cortical and subcortical projection fibers) as compared to marijuana
users, highlighting the need for further research to disentangle the effects of marijuana and
alcohol on the developing brain [18].
In general, research points to poorer white matter integrity in adolescent marijuana users
compared to non-substance using controls. While white matter findings are subtle in nature,
we have observed poorer white matter integrity correlated with poorer neurocognitive
functioning in our studies [47], which underscores the impact that slight alterations in white
matter health during this time could have on optimal cognitive functioning. Interestingly,
some preliminary evidence supports that marijuana-related toxicity on white matter integrity
may be more modest compared to the impact adolescent alcohol use has on the developing
brain, although more research in needed in this area.
Functional Imaging
fMRI Imaging—Changes in cognitive performance after acute and longer-term cannabis
use are fairly well documented, even if residual effects are suspected to largely resolve.
However, less is known on how brain functioning, or neural activation/signaling, may be
changed by marijuana use and thereby reflected in declines in neuropsychological
performance. Comparisons between blood oxygen dependent signal (BOLD) in adolescent
marijuana users and controls in response to cognitive tasks have revealed subtle differences
in brain activation patters in marijuana users. Jacobsen and colleagues (2004) were the first
to pilot an auditory working memory (n-back) fMRI study comparing marijuana users (with
tobacco use) compared to a tobacco using group and control group. The authors found
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cannabis users performed the task less accurately and failed to deactivate the right
hippocampus across conditions. In another study by the same authors, nicotine withdrawal
elicited increased activation across brain regions in the marijuana group, including parietal
cortex, superior temporal gyrus, posterior cingulate gyrus, and the right hippocampus. The
same effect was not found in the tobacco-only control group suggesting marijuana use may
lead to developmental changes masked by nicotine use [54, 55]
We have conducted several BOLD fMRI studies evaluating differences in activation patters
between our sample of abstinent marijuana users and matched controls. In 2007, we found
marijuana users to have substantially more activation than non-using peers in response to an
inhibitory processing task, particularly in parietal and dorsolateral prefrontal cortices,
suggesting additional neural resources required to maintain adequate executive control
during response inhibition [56]. In evaluating response patterns to a spatial working memory
task, adolescent marijuana users exhibited increased activation in the right parietal lobe
along with diminished activation in the right dorsolateral prefrontal cortex to achieve good
task performance, which was not observed in controls [57, 58]. In a follow-up investigation
using the same spatial working memory task, we evaluated teens with more recent
abstinence (2–7 days abstinent) compared to prolonged abstinence (27–60) from marijuana,
as well as matched controls. Recent users showed greater brain activation in prefrontal
cortices, regions needed for working memory processes, and bilateral insula [59]. In
response to a third task assessing verbal encoding, marijuana users demonstrated increased
encoding-related activation in anterior brain regions as compared to decreased activation in
posterior regions, despite no differences in task performance [20]; findings may suggest
increased recruitment of neural resources in brain areas subserving task-related processing in
marijuana using teens.
Several recent studies outside of our laboratory have shown similar findings. For example,
Jager and colleagues (2010) evaluated boys with frequent cannabis use (more than 200
lifetime cannabis use episodes) compared to matched controls (ages 13–19) and found that
cannabis users showed excessive activity in prefrontal regions in response to a working
memory task [60], studies from this same research group with young adults have yielded
similar, although modest, aberrant findings of the working memory system [61]. In 2010, an
investigation comprising chronic marijuana users and matched controls (approximately 19
years old), suggest increased activity in the prefrontal cortex in response to a task requiring
executive aspects of attention [62]. Cousijn and colleauges recently found increased
activation in heavy cannabis users (ages 18–25) in response to the Iowa Gambling task
during win evaluations in brain areas such as the insula, caudate, and temporal gyrus, which
was also positively related to weekly cannabis use; win-related increase in brain activity also
predicted increased cannabis use six months later [63] Lopez-Larson and colleagues (2012)
found differences in cortico-cerebellar activity in older adolescents with heavy marijuana
use. The authors describe decreased activation in response to a bilateral finger-tapping task,
and motor function activation was negatively correlated with total lifetime marijuana use
[64]. Age of onset also continues to play an important role, as early-onset cannabis users
(prior to age 16) demonstrated increased activation in the left superior parietal lobe in
response to a verbal working memory challenge (verbal n-back task), and earlier initiation of
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use was associated with increased BOLD activity [65]. The majority of findings suggest
increased recruitment of neural resources (possibly reflecting compensation or changes in
the efficiency of strategic neural processing) in brain areas subserving task-related
processing in marijuana using teens.
Electroencephalogram (EEG)—There has been limited research on brain functioning
using EEG among adolescent cannabis users. The strength in using EEG is the degree of
temporal resolution that is not possible with BOLD imaging. Information on the degree of
attentional bias to marijuana cues may provide some indication of brain-based differences in
cue-reactivity resulting in heavier use of marijuana among certain teenagers. For instance,
one lab based paradigm of cue reactivity found increased skin conductivity among teens
diagnosed with cannabis use disorder [66]. Nickerson and colleagues (2011) found that
among adolescents ages 14–17, P300 response (i.e., event-related potential response) was
larger among cannabis users, and response increased (along with craving) in the user group
after handling marijuana paraphernalia; findings suggest attentional bias, increased arousal,
and possible neural differences (either pre-existing or altered by ongoing substance use
engagement) that may elucidate discrepancies among teen substance use engagement [67].
Blood Perfusion—The neurovascular effect of marijuana use in adolescence has not been
studied extensively. Understanding vascular changes in cerebral blood flow (CBF) can help
us better understand neural signaling and vascular alterations that may be related to changes
in neurocognitive functioning and/or changes in neural signaling related to the BOLD signal.
Adult studies typically report increased CBF after acute exposure and lower or stabilized
CBF after a period of abstinence in heavy users, although this has varied to some degree
[68–70].
To our knowledge, there has only been one study in adolescent blood perfusion in heavy
cannabis users. In a recent study in our laboratory utilizing arterial spin labeling (ASL), we
found that heavy marijuana users (approximately 17 years old) assessed pre-and post 28
days of monitored abstinence showed reduced CBF in 4 cortical regions, including the left
superior and middle temporal gyri, left insula, left and right medial frontal gyrus, and left
supramarginal gyrus at baseline; users showed increased CBF in the right precuneus at
baseline, as compared to controls. We did not observe group differences in neurovascular
functioning after four weeks of abstinence, suggesting marijuana may influence cerebral
blood flow acutely with a possible return to baseline with prolonged abstinence [71]. A
study evaluating young adults (age range 21–27) found that acute THC administration
increased blood perfusion in areas important for emotional and cognitive processing, such as
the anterior cingulate, frontal cortex, and insula, and reduced perfusion in posterior brain
regions. Resting state activity was also altered, as THC increased baseline activity [72].
Magnetic Resonance Spectroscopy—Very few studies have looked at neurochemical
brain changes related to marijuana use in adolescence. Prescott and colleagues (2011) found
decreases in metabolite concentrations (e.g., glutamate and N-acetyl aspartate) in the
anterior cingulate, suggesting poorer underlying neuronal health in adolescent marijuana
users [73], While the exact mechanisms by which cannabis would affect neuronal health is
unclear, it is possible that modulation of neurotransmitters such as glutamate and GABA
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have adverse consequences on cellular development and neuron integrity; changes in
neuronal health is one suggested mechanism which may underlie neuroimaging and
neurocognitive findings discussed above.
Preclinical Studies
A fairly large amount of work can be found on animal models of adolescent cannabis
exposure. A detailed analysis of the preclinical studies is beyond the scope of this review,
however briefly discussing the existing literature is important for translation to human
models. Studies also focus on various cannabinoids beside Δ9-tetrahydrocannabinol (Δ9-
THC), the principal psychoactive component of marijuana; for example increasing attention
is being given to cannabidiol, a nonpsychoactive cannabinoid that may have promising
therapeutic effects independent of THC [74]. However, this brief summary will focus on
models of exposure to the natural compound or cannabinoid agonists, which mimic the
structure Δ9-THC. A great benefit of animal studies is lack of heterogeneity that corresponds
with human consumption and substance use reporting.
In animals, postnatal days 28–49 correspond with human adolescent development (which
can range from 21–59 for inclusion of early/late adolescent development) [75]. Studies
during this postnatal time period in rats have evaluated both emotional behavior as well as
cognitive/behavioral functioning. One of the first research groups to look at cannabinoid
exposure found poorer performance on cognitive tasks, such as maze learning, in immature
rats compared to mature rats treated with THC [76]. Schneider and Koch (2003, 2005) have
reported alterations in pubertal rats treated with the receptor agonist WIN, discrepancies in
performance range from sensorimotor functioning, object recognition memory, and social
behavior [77, 78]. A more recent study by Schneider and colleagues (2008) found that
chronic WIN treated pubertal rats demonstrated object/social recognition deficits, which the
authors suggest is consistent with impairment in short-term information processing.
Particularly, immature animals demonstrated more pronounced behavioral alterations as
compared to mature animals after acute exposure to WIN, and more lasting deficits in social
play and grooming behaviors [79]. Deficits in object recognition have also been reported in
male and female pubertal rats treated with a cannabinoid receptor agonist as well as THC
[80–82], and there is some support that findings are consistent across age groups.
Spatial functioning in adolescent rats has also shown affected by acute THC treatment [83].
In a recent investigation by Abush and colleagues (2012), chronic WIN treatment was found
to result in both acute and longer term effects not only in spatial memory and object
recognition, but interestingly, long term potentiation in areas such as nucleus accumbens
pathways [84]. Studies are actively evaluating emotional functioning and neurochemical
transmission in adolescent animals after exposure to cannabinoid agonists, as well as how
cannabinoids moderate state-dependent learning based on brain regions [85, 86]. While this
is not an exhaustive review of the preclinical findings, in general, the data suggest
differential and often negative impact on adolescent animals compared to adult animals
exposed to THC or other cannabinoid agonists in behavioral, emotional, and social
outcomes. The animal work is particularly important to highlight, given the consistency in
many adolescent neurocognitive and neuroimaging studies conducted with human subjects
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reporting regular use of marijuana, as the findings often point to the deleterious effects on
brain functioning compared to non-using controls.
Conclusions and Recommendations
Marijuana, second to alcohol, is the most widely used intoxicant. Approximately 25% of
adolescents (8th, 10th, and 12th grade) report being drunk in the past month and close to the
same (23%) report using marijuana in the past month [1]. As Gonzalez and Swanson point
out in a recent commentary, annual prevalence rates of high school seniors have increased
over the last decade (22% to 36%), while perceived risk of use has decreased from 80% of
seniors reporting regular marijuana use as a “great risk” in 1992 to only 45% reporting
marijuana use as risky in 2012 [1, 87]. The literature not only suggests neurocognitive
disadvantages to using marijuana in the domains of attention and memory that persist
beyond abstinence, but suggest possible macrostructural brain alterations (e.g., morphometry
changes in gray matter tissue), changes in white matter tract integrity (e.g., poorer coherence
in white matter fibers), and abnormalities of neural functioning (e.g., increased brain
activation, changes in neurovascular functioning). Earlier initiation of marijuana use (e.g.,
before age 17) and more frequent use has also been associated with poorer outcome.
It is difficult to ascertain whether reported group differences reflect pre-existing brain
architectural differences that lead to substance use and risk taking behaviors, and there is
certainly some literature that suggests as such. Nevertheless, we have seen that differences
in brain tissue integrity following heavier marijuana use does predict future risky behaviors
such as increased marijuana use and aggressive and delinquent behaviors. This suggests
imaging biomarkers may provide some clinical utility, despite the underlying pathological
processes [53].
While the focus of this overview is on the existing adolescent literature, it is important to
briefly touch on general findings in the adult literature. The amount of adult studies looking
at the acute and non-acute effects of marijuana is large and investigations typically see
changes in higher-order cognitive functioning and neural processes that are more
pronounced immediately following THC administration and may persist after prolonged
cessation of use; however current evidence suggests persisting differences are most likely
subtle in nature [5, 6, 88–90]. In both the adult and adolescent literature abstinence periods
and study designs vary widely (abstinence may vary from hours to years), and therefore
making direct comparisons continues to be a challenge and the chronicity of cognitive
alterations remains unclear. It is also unclear what defines acute versus longer-term effects
(1 week compared to 6 months, etc). Findings from our laboratory discussed in this review
reflect a “longer-term,” (residual) effect as adolescents are required to undergo a 28-day
abstinence period confirmed by urine toxicology, yet in order to really understand the effects
of this compound on the brain and cognition more rigorous study design needs to account
for longer-term follow-up periods following monitored abstinence.
Early/late initiation of use as discussed in this review is also likely to interact with severity,
frequency, and duration (and even administration) of use in both adolescent and adult
studies. Similarly, there is emerging evidence on genetic vulnerability to cannabis, and more
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information on consumed cannabis is needed as studies move sole focus from THC to other
cannabinoids (e.g., cannabidiol) that are likely to influence neural changes and in both
adolescents and adults [91, 92].
More adolescent longitudinal studies are still needed to understand both pre-existing
differences as compared to discrepancies that develop post-initiation of use. Large
longitudinal research would also help clarify the degree to which pre-existing differences
and/or chronic marijuana use during adolescence contributes to the development of
psychiatric disorders and cognitive impairment in adulthood. Furthermore, we need to better
understand the interactive relationships between alcohol and marijuana use as these
substance are commonly used together and may result in differing structural, functional, and
cognitive brain changes when used alone or in combination.
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